SREBP-dependent regulation of lipid homeostasis is required for progression and growth of pancreatic ductal adenocarcinoma
C. T. Ishida, S. L. Myers, W. Shao, M. R. McGuire, C. Liu, C. S. Kubota, T. E. Ewachiw, D. Mukhopadhyay, S. Ke, H. Wang, Z. A. Rasheed, R. A. Anders, P. J. Espenshade
This study shows that SREBP pathway inhibition slows PDAC tumor growth by disrupting lipid homeostasis, suggesting SCAP as a therapeutic target.
Cancer Research Communications · Sep 27, 2024Peer-reviewedCancer Biology